Brokerages Expect INC Research Holdings Inc (INCR) Will Post Earnings of $0.59 Per Share
Wall Street analysts expect INC Research Holdings Inc (NASDAQ:INCR) to report earnings per share (EPS) of $0.59 for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for INC Research’s earnings, with estimates ranging from $0.55 to $0.74. INC Research posted earnings per share of $0.67 in the same quarter last year, which would indicate a negative year over year growth rate of 11.9%. The company is scheduled to report its next earnings results on Tuesday, February 27th.
On average, analysts expect that INC Research will report full-year earnings of $2.39 per share for the current year, with EPS estimates ranging from $2.14 to $2.60. For the next financial year, analysts forecast that the firm will report earnings of $2.57 per share, with EPS estimates ranging from $2.37 to $3.10. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for INC Research.
INC Research (NASDAQ:INCR) last announced its quarterly earnings data on Thursday, November 9th. The company reported $0.54 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.63 by ($0.09). INC Research had a negative net margin of 4.29% and a positive return on equity of 14.42%. The business had revenue of $592.21 million during the quarter, compared to analyst estimates of $604.95 million. During the same period in the prior year, the firm earned $0.64 earnings per share. The firm’s revenue for the quarter was up 128.2% compared to the same quarter last year.
INC Research (INCR) traded down $0.80 during mid-day trading on Monday, reaching $40.50. The company had a trading volume of 1,480,000 shares, compared to its average volume of 1,380,000. INC Research has a fifty-two week low of $33.60 and a fifty-two week high of $61.10. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.99. The firm has a market cap of $4,230.00, a P/E ratio of -71.05, a P/E/G ratio of 1.27 and a beta of 1.09.
Several institutional investors have recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of INC Research by 14.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock worth $103,000 after purchasing an additional 228 shares during the last quarter. Victory Capital Management Inc. raised its stake in shares of INC Research by 17.6% in the second quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock worth $139,000 after purchasing an additional 356 shares during the last quarter. Oregon Public Employees Retirement Fund raised its stake in shares of INC Research by 4.9% in the third quarter. Oregon Public Employees Retirement Fund now owns 20,946 shares of the company’s stock worth $1,095,000 after purchasing an additional 986 shares during the last quarter. Comerica Bank raised its stake in shares of INC Research by 3.1% in the third quarter. Comerica Bank now owns 43,790 shares of the company’s stock worth $2,483,000 after purchasing an additional 1,331 shares during the last quarter. Finally, Strs Ohio raised its stake in shares of INC Research by 5.6% in the third quarter. Strs Ohio now owns 26,600 shares of the company’s stock worth $1,391,000 after purchasing an additional 1,400 shares during the last quarter. 99.50% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This article was originally published by Marea Informative and is the property of of Marea Informative. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.mareainformativa.com/2018/01/29/brokerages-expect-inc-research-holdings-inc-incr-will-post-earnings-of-0-59-per-share-updated-updated-updated.html.
About INC Research
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for INC Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research and related companies with MarketBeat.com's FREE daily email newsletter.